News Industry News Amgen Completes Enrollment In Large Cardiovascular Outcomes Trial Of Repatha™ (Evolocumab) In Patients With High Cholesterol And Clinically Evident Cardiovascular Disease June 05, 2015
News Daily News Low Trial Participation Rate of MI Patients Raises Questions of Applicability Todd Neale September 02, 2014
News Features Advocacy Group Blasts Mobile Cardiovascular Screening Company for ‘Unethical’ Practices Yael L. Maxwell June 27, 2014
News Conference News TCT 2013 Innovation in Intervention: Perspectives from Industry October 30, 2013
News Daily News For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs July 25, 2013
News Daily News En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida July 25, 2013
News Daily News Public Reporting of PCI Readmissions Unveiled, Though Results Questioned by Some Caitlin E. Cox July 25, 2013
News Daily News FDA, CMS Parallel Review Aims to Speed Access to Innovative Technologies L.A. McKeown October 14, 2011
News Conference News PARTNER: TAVI Cost Effective Compared With Standard Care Jason Kahn April 03, 2011